AllTranz is developing a unique set of dermal delivery products utilizing proprietary technology platforms.
AllTranz is a specialty pharmaceutical company utilizing transdermal drug delivery technology to developing products addressing pain. The company is developing patent protected patch, gel, and microneedle products that offer many advantages to existing products on the market. The lead product is a THC prodrug patch, which is on the verge of entering human clinical trials. AllTranz products also incorporates abuse deterrent technology.